No Data
No Data
Huaxia Eye Hospital Group Co.,Ltd.'s (SZSE:301267) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Huaxia Ophthalmology (301267.SZ): No products related to AI glasses have been involved yet.
Huaxia Ophthalmology (301267.SZ) stated on the investor interaction platform on August 15 that the company's main business is medical services in ophthalmology, and it has not yet involved products such as AI glasses.
Huaxia Eye Science and Technology (Stock Code: 301267.SZ) has repurchased 0.78% of its shares.
On August 1st, Gelunhui reported that Huaxia Eye Science and Technology (301267.SZ) had repurchased a total of 6,581,440 shares of the company through a stock repurchase securities account using a centralized bidding trading method as of July 31, 2024, accounting for 0.78% of the company's current total share capital. The highest transaction price was 30.93 yuan/share, the lowest transaction price was 19.38 yuan/share, and the total transaction amount was 18.1 million yuan (excluding transaction fees).
Should You Buy Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) For Its Upcoming Dividend?
The Returns At Huaxia Eye Hospital GroupLtd (SZSE:301267) Aren't Growing
Huaxia Eye (301267.SZ): Cumulative expenditure of 176 million yuan to repurchase 6.3124 million shares.
On July 1st, Gelonghui reported that Huaxia Ophthalmology (301267.SZ) has cumulatively repurchased 6,312,440 shares of the company through a share repurchase special account for centralized auction trading method as of June 30th, 2024, accounting for 0.75% of the company's current total share capital. The highest fill price was 30.93 yuan/share, the lowest fill price was 20.69 yuan/share, and the total fill amount was 175,978,500 yuan (excluding transaction costs).
No Data